Baraclude 0.5mg Tablet (Entecavir 0.5 mg)
Prescription RequiredManufactured By
Bms india pvt ltd
Pack Of
30
Salt Composition
Entecavir 0.5 mg
Storage
Keep in cold place
ALL SUBSTITUTES
Cronivir 0.5mg Tablet
Entehep 0.5mg Tablet
X-vir 0.5mg Tablet
Overview
Baraclude 0.5mg Tablet (Entecavir) is an antiviral prescription-based medicine used in the treatment of hepatitis B virus (HBV) infection under doctor guidance. Entecavir is the active salt of the medicine present in a 0.5 mg strength. The medicine belongs to the drug class of nucleoside analogue antiviral therapy.
It works by blocking the viral DNA polymerase enzyme, which is essential for the replication of hepatitis B virus. By blocking this enzyme, the medicine stops the multiplication of virus and reduces the viral load in the body. The medicine is prescribed for adults and children aged 2 years and older but under doctor's prescription.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | baraclude |
| Generic / Active Ingredient | Entecavir |
| Strength | 0.5 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | bms india pvt ltd |
| Pack Size | 30 |
| Prescription Required | Yes |
| Therapeutic Categories | Hepatitis Medicines |
| Uses | hepatitis |
Uses and Indications
Hepatitis B
Side Effects of Baraclude 0.5mg Tablet
The use of the Baraclude 0.5mg Tablet (Entecavir) may lead to certain side effects, as it interferes with viral activity and normal body processes. Some of them are resolved on their own, and some need proper medical attention.
Here are some common side effects, but if they worsen, the patient should visit the doctor immediately.
● Headache
● Fatigue
● Nausea
● Dizziness
● Severe liver problems
● Lactic acidosis
● Worsening of hepatitis after stopping the medicine
Baraclude 0.5mg Tablet Dosage and How To Take It
The typical dosage of Entecavir 0.5mg Tablet (Baraclude) depends on the patient’s age and overall health condition. Take the tablet on an empty stomach at least 2 hours before or after food for better absorption and optimal effectiveness of the treatment.
It should be taken at the exact time every day without skipping. Consistency is important to achieve the best possible result.
Safety Advice for Baraclude 0.5mg Tablet
- ● Alcohol: Avoid alcohol while using the Baraclude 0.5mg Tablet, as this puts extra strain on the liver, which may worsen liver function and reduce the effectiveness of the treatment.
- ● Driving: Do not drive or work with machinery while taking the Entecavir 0.5mg Tablet (Baraclude) in case you experience dizziness, tiredness, or feeling unwell. These conditions can make you less alert and reduce your concentration; hence, it’s crucial that you should be careful while experiencing them.
- ● Pregnancy: Pregnant women are usually told to avoid taking the Baraclude 0.5mg Tablet (Entecavir) as the safety of the medicine in pregnancy is unknown. It must only be taken if strictly directed by a physician after considering the benefits and risks.
- ● Breastfeeding: A Baraclude 0.5 mg tablet can be excreted through breast milk; however, the effect of the drug on the nursing baby has not been determined yet. For this reason, breastfeeding women have to take this medication strictly under medical supervision.
- ● Kidney: Entecavir 0.5mg Tablet (Baraclude) may affect liver function, as it is removed from the body through the kidneys, so dose adjustment may be required in patients with kidney problems.
- ● Liver: Baraclude 0.5mg Tablet (Entecavir) is used in the treatment of hepatitis B; thus, the liver's functioning needs to be monitored regularly. Liver Function Tests (LFTs) are carried out to know about the effectiveness of the drug and liver function.
FAQs About Baraclude 0.5mg Tablet
1. Is Entecavir 0.5mg Tablet (Baraclude) safe for long-term use?
Yes, the Baraclude 0.5mg tablet can be administered for the treatment of hepatitis B in the long run; however, its consumption must be strictly controlled by a physician. This is done to track the progress and safety of the patient while consuming this tablet.
2. What precautions must be taken before taking Baraclude 0.5mg Tablet?
Patients should inform their doctor if they have any ongoing kidney or liver treatment or a history of kidney or liver disease before starting the Baraclude 0.5mg Tablet.
3. When Baraclude 0.5mg Tablet (Entecavir) start to show result?
Baraclude 0.5mg Tablet may start reducing the viral load within a few weeks of regular use but noticeable improvement may take several weeks to months. Complete the full course of the treatment to reduce the risk of reoccurrence of disease.
4. What medical advice should be followed while taking Entecavir 0.5mg Tablet (Baraclude)?
Patients should strictly follow all given instructions carefully by the healthcare professional. Also regular follow ups are essential in order to avoid complications during the treatment.
5. Can I stop Baraclude 0.5mg Tablet (Entecavir) on my own?
No, stopping Baraclude without doctor advice may result in various side effects that disturb the treatment outcome.
References
● Shaw, T., & Locarnini, S. (2004). Entecavir for the treatment of chronic hepatitis B. Expert review of anti-infective therapy, 2(6), 853-871.
● Matthews, S. J. (2006). Entecavir for the treatment of chronic hepatitis B virus infection. Clinical therapeutics, 28(2), 184-203.
Robinson, D. M., Scott, L. J., & Plosker, G. L. (2006). Entecavir: a review of its use in chronic hepatitis B. Drugs, 66(12), 1605-1622.
● Lai, C. L., Shouval, D., Lok, A. S., Chang, T. T., Cheinquer, H., Goodman, Z., ... & Fernandes, L. (2006). Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. New England Journal of Medicine, 354(10), 1011-1020.
● Chang, T. T., Lai, C. L., Kew Yoon, S., Lee, S. S., Coelho, H. S. M., Carrilho, F. J., ... & Iloeje, U. (2010). Entecavir treatment for up to 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B. Hepatology, 51(2), 422-430.
Marketer Details
Bms india pvt ltd
Author Details
Written By:
Nonish Sharma
I am a medical content writer with a strong academic background in life sciences, holding an M.Sc. in Biotechnology... Read More
Reviewed By:
Vaibhav Shakya
Dr. Vaibhav Shakya, MD, is a Medical reviewer and medicine expert at Globans Pharma, with more than 9 years of experienc... Read More
Want to know More
Check our Editor Policy
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.
